217 filings
Page 4 of 11
8-K
tkvafx
10 Feb 23
Orchard Therapeutics Announces Proposed ADS Ratio Change
7:26am
8-K
us0 5ynqnkp466c7oswf
9 Jan 23
Orchard Therapeutics Highlights Recent Progress Across HSC Gene Therapy Portfolio and Outlines Key 2023 Milestones
7:13am
8-K
ccpw843d6c3s
5 Jan 23
Orchard Therapeutics Announces U.S. FDA Clearance of IND Application for OTL-203 in MPS-IH
7:05am
8-K
hikuc7zk3
12 Dec 22
Regulation FD Disclosure
4:22pm
8-K
v0p3flnd72b9qpmkedm2
14 Nov 22
Orchard Therapeutics Reports Third Quarter 2022 Financial Results and Reviews Recent Business Highlights
7:10am
8-K
dk0 74e9pde
6 Oct 22
Entry into a Material Definitive Agreement
4:34pm
424B5
m01vkrrq
6 Oct 22
Prospectus supplement for primary offering
4:12pm
S-8
uv65tj4ef7
4 Aug 22
Registration of securities for employees
7:40am
8-K
b2rcfl6
4 Aug 22
Orchard Therapeutics Reports Second Quarter 2022 Financial Results and Reviews Recent Business Highlights
7:05am
8-K
25i0804n23ah0eph
10 Jun 22
Submission of Matters to a Vote of Security Holders
7:00am
8-K
ddc56wctju8qj
12 May 22
Orchard Therapeutics Reports First Quarter 2022 Financial Results and Highlights Recent Commercial Progress
7:05am
EFFECT
koui6ax kh9tjqhc5
2 May 22
Notice of effectiveness
12:15am
CORRESP
j9mklajwt9orz
27 Apr 22
Correspondence with SEC
12:00am
8-K
kje84bf62vpes155u
8 Apr 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:15pm
UPLOAD
575e8alvkisc4rcbv
5 Apr 22
Letter from SEC
12:00am
S-3
vzndt
30 Mar 22
Shelf registration
8:26am